While we found no difference in the expression of RORγt in CD4 T cells by T2D status, we found a significant increase in circulating Th17 cell subsets defined by cell surface markers and chemokine receptors (40, 41). The gene discussed is CD4; the disease is type 2 diabetes mellitus.